a 6-week double-blind comparison of mianserin , a new antidepressant , and amitriptyline allowed us to explore the problem of demonstrating main effect differences in drug/drug trials when the focus is primarily only upon efficacy or upon common adverse symptomatology .
C0003289
antidepressant
C0002600
amitriptyline